深圳市新生儿疾病筛查成本-效益分析  

Cost-Benefit Analysis of Neonatal Screening Project in Shenzhen

作　　者：林艳[1] 黄晓春[1] 文伟[1] 陈晚秋[1] 赵光临[1] 

机构地区：[1]深圳市妇幼保健院,广东深圳518028

出　　处：《中国社会医学杂志》2012年第3期214-216,共3页Chinese Journal of Social Medicine

基　　金：深圳市科技计划项目(200903108)

摘　　要：目的评估深圳市新生儿疾病筛查方案的经济效益。方法根据深圳市新生儿疾病筛查结果、调查所得数据和深圳市经济数据,测算新生儿疾病筛查的成本和效益。结果深圳市开展新生儿疾病筛查的净效益为5.4亿元,先天性甲状腺功能减低筛查的成本-效益比为1∶19.83,苯丙酮尿症筛查的成本-效益比为1∶2.83,葡萄糖-6-磷酸脱氢酶缺乏症筛查的成本-效益比为1∶141.96,半乳糖血症筛查的成本-效益比为1∶1.17。结论深圳市新生儿疾病筛查工作具有良好的经济效益,优化筛查方案可进一步提高筛查率和复查率。Objectives To evaluate the economic returns of neonatal screening project in Shenzhen. Methods The cost and benefit was calculated according to the screening data,investigation data and economics data in Shenzhen. Results The net benefit of neonatal screening project in Shenzhen is 5.40 billion yuan,the cost-benefit ratio of congenital hypothyroidism was 1∶19.83,the cost-benefit ratio of phenylketonuria was 1∶2.83,the cost-benefit ratio of glucose-6-phosphate dehydrogenase was 1∶141.96,and the cost-benefit ratio of galactosemis was 1∶1.17. Conclusions Neonatal screening project in Shenzhen has huge economic returns and should be optimized to increase the screening rate and recheck rate.

关 键 词：新生儿疾病筛查 成本-效益 分析 

分 类 号：R174[医药卫生—妇幼卫生保健]